Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
If youd like to find out more and see whether this treatment is suitable for you, book in a complimentary consultation with one of our medical professionals
Body Composition & Fat Loss Research: When the primary endpoint is a shift in lean mass versus fat mass, cycles are often more moderate in length
Before considering any incretin-based medicine, prepare a clear medication list, weight and glucose history, prior pancreatitis or gallbladder history, thyroid cancer history, pregnancy plans, and previous side effects from similar drugs
Martorell, J.M
Summary: Retatrutide's long-term side effects are not yet fully established, but current trial data indicate gastrointestinal effects, increased resting heart rate, and potential risks consistent with the GLP-1 receptor agonist drug class
Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study
